Article Details

Startup developing semi-synthetic protein therapies raises $63M to tame IL-2

Retrieved on: 2018-04-29 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Startup developing semi-synthetic protein therapies raises $63M to tame IL-2. View article details on hiswai:

Excerpt

<div>San Diego-based Synthorx has brought in $63 million in Series C financing to advance its efforts to produce semi-synthetic protein therapies for cancer and immune conditions. The funding round was led by OrbiMed with others such as Medicxi, Osage University Partners, <b>Avalon Ventures</b>, RA Capital ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up